UK High Court strikes down Herceptin patents

14-04-2014

UK High Court strikes down Herceptin patents

Photo: lucarista / Shutterstock.com

The UK High Court has invalidated two patents covering Roche’s breast cancer drug Herceptin (trastuzumab) after a challenge by generic drug maker Hospira.


Herceptin, UK High Court, patent invalidation, Roche, Genentech

LSIPR